Academic Journal
Q1Gastric Cancer
About Gastric Cancer
Gastric Cancer is a scholarly journal published by Springer. SCImago 2025 lists it in Q1, with an SJR of 2.489 and H-index of 114.
Coverage: 2000-2026. Research categories: Cancer Research (Q1); Gastroenterology (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1).
Verified field sources
- Journal Impact Factor: 5.1 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2024 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Editor(s): Yasuhiro Kodera MD, PhD, FACS; Giovanni de Manzoni MD (Editors-in-Chief) — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Gastric Cancer Management and Outcomes; Helicobacter pylori-related gastroenterology studies; Gastrointestinal Tumor Research and Treatment; Esophageal Cancer Research and Treatment; Metastasis and carcinoma case studies; Colorectal Cancer Treatments and Studies.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,590.00 USD; 5,490.00 EUR
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
From operating room to pathology report: Delphi consensus on pathological assessment of peritoneal cytology and biopsies in staging laparoscopy for gastric cancer
Judith S. E. Quik, Micha J. de Neijs, Heike I. Grabsch, Niels A. D. Guchelaar et al.
2026-10-03 · DOI: 10.1007/s10120-026-01803-1Longitudinal assessment of quality-of-life after gastrectomy for gastric cancer: a prospective study
Shinji Kuroda, Yoshihiko Kakiuchi, Yudai Mimata, Hitoshi Minagi et al.
2026-10-01 · DOI: 10.1007/s10120-026-01805-zComparison of geriatric assessment with provider’s clinical assessment among older adults with gastroesophageal cancer
Namrata Vijayvergia, Caitlin R. Meeker, Meghan Connors, Elizabeth A. Handorf et al.
2026-09-24 · DOI: 10.1007/s10120-026-01787-yIGF2-associated tumor cells and APOE-positive macrophages define an imatinib resistance-associated niche in gastrointestinal stromal tumors
Mu Su, Chengqian Lv, Ruiyang Zhai, Yu Li et al.
2026-09-18 · DOI: 10.1007/s10120-026-01802-2A multicenter phase II trial of ramucirumab plus irinotecan for early recurrence of gastric cancer during or after adjuvant chemotherapy with docetaxel plus S-1 therapy: the RAMIEL trial (OGSG1901)
Toshifumi Yamaguchi, Ryohei Kawabata, Yusuke Akamaru, Hidekazu Hirano et al.
2026-09-16 · DOI: 10.1007/s10120-026-01799-8Clinicopathological characterization of extremely low-grade fundic gland tumors: a study of 11 of a variant of oxyntic gland adenomas
Sunao Akiyama, Takashi Yao, Tetsuya Tanihira, Tatsushi Suwa et al.
2026-09-14 · DOI: 10.1007/s10120-026-01801-3Sensitivity and specificity of endoscopic and radiographic screening for localized gastric cancer in a real-world, population-based setting
Choy-Lye Chei, Sho Nakamura, Kaname Watanabe, Hiroaki Saito et al.
2026-09-09 · DOI: 10.1007/s10120-026-01797-wExternal validation and comparison of five prediction models for lymph node metastasis after noncurative endoscopic submucosal dissection for early gastric cancer
Ayaka Takasu, Waku Hatta, Takuji Gotoda, Yohei Ogata et al.
2026-09-07 · DOI: 10.1007/s10120-026-01798-9Clinical impact of CT-defined sarcopenia on long-term oncological outcomes in gastric cancer: validation of muscle mass cut-offs established according to EWGSOP recommendations
Jasmin Hasanovic, Paul Friedrich Esslinger, Veronika Lummer, Heiner Nebelung et al.
2026-09-03 · DOI: 10.1007/s10120-026-01796-xCorrection: Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study
Oscar Hou In Chou, Vinod Kumar Chauhan, Cheuk To Skylar Chung, Lei Lu et al.
2026-08-31 · DOI: 10.1007/s10120-026-01789-wPhase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G
Toshiki Masuishi, Hiroki Hara, Takayuki Ando, Takeshi Kawakami et al.
2026-08-27 · DOI: 10.1007/s10120-026-01790-3Prognosis-predicting factor of gastrectomy after systemic cancer therapy for cStage IVB gastric cancer
Takumi Habu, Takahiro Kinoshita, Daiki Terajima, Izuma Nakayama et al.
2026-08-26 · DOI: 10.1007/s10120-026-01795-yCorrection: Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects
Komei Kuge, Junko Mukohyama, Yoshimi Yasukawa, Yuko Ishibashi et al.
2026-08-25 · DOI: 10.1007/s10120-026-01794-zPrimary outcomes of a phase II trial of laparoscopic/robotic total gastrectomy with spleen-preserving splenic hilar dissection for locally advanced proximal gastric cancer involving the greater curvature (JCOG1809)
Takahiro Kinoshita, Masayuki Yokoyama, Junya Kitadani, Takeshi Omori et al.
2026-08-24 · DOI: 10.1007/s10120-026-01792-1Mesenchymal R-spondin 3 promotes an immunogenic tumor microenvironment with adaptive immune resistance in human gastric adenocarcinoma
Anne-Sophie Fischer, Alexander Arnold, Hilmar Berger, Stefanie Müllerke et al.
2026-08-24 · DOI: 10.1007/s10120-026-01791-2Correction: Identification of patients at risk for poor survival among those with normal skeletal muscle mass: a multicenter retrospective validation study in gastric cancer
Ryota Matsui, Kazuyoshi Yamamoto, Yoshiro Yukawa, Masayoshi Terayama et al.
2026-08-21 · DOI: 10.1007/s10120-026-01793-0Comparison of surgical outcomes in laparoscopic gastrectomy for advanced gastric cancer between Japanese and Italian cohorts: an international, propensity score-matched investigation (the Shinkansen Study)
Pietro Maria Lombardi, Mitsumasa Yoshida, Gian Luca Baiocchi, Etsuro Bando et al.
2026-08-11 · DOI: 10.1007/s10120-026-01788-xBaseline IL-6 independently predicts severe immune-related toxicity and poor survival in advanced gastric cancer treated with immunotherapy
Wanrong Liu, Hui Tang, Ningning Li, Wei Qiu et al.
2026-09 · DOI: 10.1007/s10120-026-01744-9Correction: IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2
Ju Huang, You-xiang Chen, Bo Zhang
2026-09 · DOI: 10.1007/s10120-026-01786-zCorrection: Diagnostic discordance and treatment-associated change of PD-L1 and CLDN18.2 in gastric cancer: a real-world analysis of paired biopsy–resection samples
Donghe Yu, Tong Xie, Siyuan Cheng, Cheng Liu et al.
2026-09 · DOI: 10.1007/s10120-026-01785-0Reviews
Community Reviews
Version History
September 25, 2026 at 6:41 am
September 20, 2026